First published · Last updated
PT1.07.04 Radiomics Model Based on Synthesized PET for Predicting Neoadjuvant Therapy Pathologic Response in NSCLC (CPT-LC-NEO Trial)
A journal article describing a radiomics model that uses synthesized PET imaging to predict pathological response to neoadjuvant therapy in non-small cell lung cancer. The item is listed as part of the CPT-LC-NEO trial and published by Elsevier BV.
Categories: science-and-space, public-health
Generated scores
Scores are based on the cited reporting and use a 1–10 scale. Read the methodology.
- Confidence
- 5/10
- Geographic reach
- 1/10
- Global importance
- 3/10
- Impact magnitude
- 2/10
- Positivity
- 5/10
- Urgency
- 1/10
Why it matters
The paper presents a medical-imaging prediction model aimed at assessing treatment response in NSCLC.

